Stock Evaluator: LENSAR, Inc. (LNSR)

LENSAR, Inc. LNSR

$4.85 -0.06 -1.22%
November 18, 2026 4:00:00 PM EST November 10, 2021 Volume: 58,092
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Commentary & Analysis


Financial Summary

Share Statistics LNSR Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $59.6 $370.8 18%
Shares Out (Mil) 12.4 41.4 24%
Institutional Ownership 64.2% 82.9% 40%
Float (Mil) 8.8 37.4 18%
Beta 1.03 0.89 61%
Avg Daily Volume (000s) 99 323 36%
Price Change
(52-week)
(50.8%) 57.7% 20%
Growth LNSR Industry
Median
Percentile
(All Stocks)
Sales (5yr) 17.2% 11.8% 77%
Net Income (5yr) (11.6%) (5.7%) 28%
EPS (5yr) 7.7% 10.6% 43
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (15.3%) (15.8%) 49%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 1 1 1
Current EPS ($0.140) $0.070 ($0.850)
Month Ago EPS ($0.100) ($0.050) ($0.510)
# Rev Up 0 1 0
# Rev Down 1 0 1
Three Months Ago EPS na na na
Year/Year Chg (63.3%) (102.4%) (87.4%)
Financials LNSR Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $60 $125 21%
Net Income (TTM) (Mil) $34 ($9) 51%
EPS (TTM) $1.316 ($0.300) 64%
Operating Cash Flow (TTM) (Mil) ($5) ($1) 26%
Net Cash Flow (TTM) (Mil) $5 $2 54%
Long-Term Debt (Q1) (Mil) $1 $21 18%
Enterprise Value (Q1) (Mil) $64 $381 19%
Valuation LNSR Industry
Median
Percentile
(All Stocks)
P/B 5.39 2.52 83%
P/E 8.6 26.1 14%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 1.1 1.3 52%
Ratios LNSR Industry
Median
Percentile
(All Stocks)
Gross Margin 52.0% 59.5% 64%
Net Margin 56.1% (4.5%) 98%
ROA 49.1% (10.1%) 99%
ROE (454.0%) (8.5%) 1%
Liabilities to Assets 62.9% 45.8% 58%
F-Score 5 4 50%

Passing Stock Screens

As of 11/18/2026, from a list of 60 stock screening strategies, LNSR meetings the criteria of 1 screen:

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors